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Summary. Experimental arthritis developed in rats
injected intraperitoneally with aqueous suspensions of
peptidoglycan-polysaccharide complexes (PG-APS)
isolated from group A streptococcal cell walls. Reduc-
tion of serum complement by pretreatment with cobra
venom factor (COV) reduced acutejoint inflammation
over the first 3 days following injection of PG-APS.
Thereafter, the course of the disease was not different
in the COV-treated rats. The serum levels of comple-
ment were depressed below detectable levels by 24 hr
in rats injected only with cell walls, but rebounded to
normal levels or above 3 days after injection. In rats
injected with COV before cell walls, the complement
levels also increased 3 days after injection ofcell walls,
in contrast to sustained depressed levels in rats injected
only with COV. The correlation between severity of
joint inflammation and serum complement levels at
day 3 was positive in COV-treated rats. The quantity
of cell wall per joint at day 3 correlated with the
severity ofjoint disease. However, COV treatment did
not alter the amount of cell wall localized in joint
tissue. Therefore, although complement does appear
to have a role in early joint inflammation, its effect is
not upon the transport of cell wall into joint tissue.
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INTRODUCTION
Chronic, remittent, erosive synovitis is produced by
intraperitoneal (i.p.) injection of rats with an aqueous
suspension of group A streptococcal cell wall frag-
ments (Cromartie, Craddock, Schwab, Anderle &
Yang, 1977). The disease has a biphasic course with an
initial acute inflammation ofthe ankle, wrist and small
joints of the extremities which reaches a peak at about
3 days and then recedes, to be followed by a chronic,
remittent phase progressing over a period of several
months to joint destruction (Dalldorf, Cromartie,
Anderle, Clark & Schwab, 1980). The purified arthri-
togenic cell wall fragments consist of the covalently
bound peptidoglycan-group-specific polysaccharide
polymer (PG-APS).
Investigation into the mechanism of tissue injury
includes consideration of the role of complement,
since products of the complement system can partici-
pate in several phases of the inflammatory response
such as increased vascular permeability, chemotaxis
and activation of monocytes (Miiller-Eberhard, 1975;
Schorlemmer, Bitter-Suermann & Allison, 1977). It
has been shown that the peptidoglycan moiety of
groupA streptococcal cell walls is a potent activator of
the alternative complement pathway (ACP) in vitro
(Greenblatt, Boackle & Schwab, 1978) and that
changes in the ACP occur in vivo in rats injected with
arthropathogenic doses ofPG-APS (Lambris, Allen &
Schwab, 1982). Complement has also been implicated
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in other models of chronic inflammation (Schor-
lemmer et al., 1977; Keystone, Schorlemmer, Pope &
Allison, 1977) and complement activation is asso-
ciated with rheumatoid arthritis (Ruddy & Austen,
1970).
This paper examines the relationship of serum
complement to the severity of joint inflammation
induced with PG-APS and to the quantity ofPG-APS
localized in joint tissue.
MATERIALS AND METHODS
Bacterial cell-wall preparations
The details have been described (Cromartie et al.,
1977). Briefly, group A, type 3, strain D-58 strepto-
cocci were grown in Todd-Hewitt broth (Difco,
Detroit, Mich.) for 16 hr at 37°. The cells were
harvested by centrifugation, washed, and disrupted in
a Braun shaker (Bronwell Scientific Co., Rochester,
New York). Cell walls were collected by differential
centrifugation, treated with trypsin and ribonuclease
and washed five times. Cell-wall fragments were
prepared by suspending cell walls in pH 7-2 phos-
phate-buffered saline (PBS) and subjecting them to
sonic treatment for 70 min in a Branson Model 350
sonifer (Branson Sonic Power Co., Danbury, Conn.).
After sonication the walls were passed through a
millipore 0 45 gm filter (Millipore Corp., Bedford,
Mass.), and the concentration of rhamnose, N-acetyl
glucosamine and N-acetyl muramic acid measured by
gas chromatography. Sterility was confirmed by cul-
ture on blood agar plates.
Animals and induction of arthritis
Outbred, Sprague-Dawley rats were purchased from
Zivic-Miller, Allison Park, Pa. Females weighing
approximately 125 g were injected intraperitoneally
with sonicated, filtered cell-wall fragments suspended
in pH 7 2 PBS.
All rats were observed daily for development of
joint disease. The severity was graded using a scale of0
to 4 for each leg (maximum score 16). The score was
based upon the extent oferythema and oedema of the
periarticular tissues and the enlargement, distortion or
ankylosis of joints.
Cobra venom factor
Cobra venom factor (COV) was obtained from Cordis
Laboratories, Inc., Miami, Fla. Rats were injected
intravenously with a dose of 250 units per kg divided
into five injections spaced over a period of 24 hr, as
described by Cochrane, Muller-Eberhard & Aikin
(1970). Control rats were injected with PBS.
Measurement ofserum complement
Lightly anaesthesized rats were bled from the tail into
iced tubes. Blood was clotted at room temperature for
30 min and the serum separated and stored at - 70°
until complement analysis. Total serum haemolytic
complement activity was determined by a kinetic
method measuring time to 50% haemolysis of sensit-
ized sheep erythrocytes, as described by Greenblatt et
al. (1978).
Measurement of cell wall in tissue
The procedure of solid phase radioimmunoassay
(RIA) has been described in detail by Eisenberg, Fox,
Greenblatt, Anderie, Cromartie & Schwab, (unpub-
lished observations). Briefly, polyvinyl microtitre
plate wells were coated with F(ab')2 fragments of
rabbit anti-group A carbohydrate antibody (specific
for N-acetyl-D-glucosamine). The plate was further
non-specifically coated with TRIS buffer containing
human serum albumin 0-1% and Tween 80 0-1%.
Homogenized joint extracts were then applied in 1/10
dilution. After further incubation, the IgG fraction of
rabbit anti-group A carbohydrate was added. Finally,
the assay was developed with radioiodinated sheep
anti-rabbit IgG Fc fragment (David & Feisfeld, 1974).
Individual wells were cut out and counted in an
automated gamma scintillation counter. Results
obtained with each sample were referred to a standard
curve made with RIA data from cell wall sonicates and
fitted to a third degree equation by computer.
Histological sections and stains
Three days after the intraperitoneal injection of cell
wall fragments, six rats from each group were killed.
Complete autopsies were performed and all four
extremities were removed, opened, and fixed in phos-
phate-buffered formalin. One hind foot and ankle was
decalcified, cut longitudinally, and sectioned for histo-
logical study. Sections from all these tissues were
stained with haematoxylin-eosin (H & E) or periodic
acid-Schiff (PAS) reagents. The remaining extremities
were processed for cell-wall measurement by RIA.
Sections of the ankle joint were evaluated for the
presence of cell wall material by PAS staining and by
immunofluorescence with antibody specific for group
A polysaccharide. The subcutaneous tissues and syno-
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Figure 1. Serum complement levels in rats injected with cell
walls (CW) (0); COV followed by cell walls (0); or COV
alone (U). Serum was collected at 6, 24 and 72 hr after
injection of cell wall. The normal serum value (100%) is from
the pooled serum oftwelve rats injected with PBS. Each point
represents one rat.
via of each joint were also evaluated for the presence
and severity of the associated acute inflammatory
reaction. These histological changes were graded















Effect of cell wall and/or COV on serum complement
levels
A group of twenty-six rats was pretreated with COV.
Six hours after the last injection twenty of these rats
were injected i.p. with cell wall in a dose of 50 pg
rhamnose per g body weight. The remaining six served
as COV controls and were injected with PBS instead of
cell walls. A second group of twenty-six rats received
five intravenous (i.v.) injections ofPBS over 24 hr and
fourteen of these were then injected i.p. with cell wall.
Twelve ofthe second group were injected i.p. with PBS
and their serum was pooled to provide the normal
serum haemolytic complement base line (100% level of
complement). At 6, 24 and 72 hr after injection of cell
walls, serum was collected from all groups for comple-
ment measurement. Only six of the rats injected with
cell wall and six of the rats injected with COV and cell
wall were bled at 6 and 24 hr. In previous experiments,
the range of complement activity in individual serum
samples collected from ten PBS-injected control rats,
at eight intervals over a period of 11 days, was
35%-195% of a standard serum pool (Lambris et al.,
1982).
The relative levels ofserum haemolytic complement
are shown in Fig. 1. The regimen of COV treatment
reduced haemolytic activity below detectable levels
(< 10% of normal rat serum) for at least 3 days in
5/6 COV control rats. Injection of rats with cell wall
only also reduced the serum complement levels by 24
hr, although at 6 hr the levels were highly variable. By
72 hr, in the group receiving only cell wall, the
2 6 10 14 18 22
Days after cell wall injection i.p.
Figure 2. Mean values ofjoint scores (four legs, maximum score 16) at intervals after injection ofcell-wall fragments in rats given
COV before cell wall (O --- 0) and in control rats given PBS before cell wall (0 0). Initially fourteen rats per group; six rats
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Figure 3. Correlation ofjoint score (total of four legs) with relative level of serum complement 3 days after injection of cell-wall
fragments in rats pretreated with COV. Each point represents one rat. Correlation coefficient (r) is 0-6 with a significance of
P<0005.
complement level in nearly all rats had recovered and
13/14 had rebounded to normal levels or above. In
contrast to the rats given COV only, the complement
activity often rats given COV and cell walls was also in
the normal range at 72 hr (Fig. 1).
Effect of COV on development of joint inflammation
On days 1 to 3 after cell wall injection the joint scores
of rats injected with COV before cell-wall fragments
were signficantly less than control rats given PBS
before cell wall (Fig. 2). Thereafter, no difference
between the groups was observed. The average time
required to reach a peak of acute joint inflammation
(Cromartie et al., 1977) was 3 9 days for the COV-
treated group compared with 2-9 days for the control
rats. The incidence of recurrent joint inflammation
was 3/8 rats in each group. On day three, the joint
score correlated positively with level ofserum comple-
ment in the group given COV and cell wall (r=0-6,
P> 0 005, Fig. 3). There was no significant correlation
in the group injected only with cell wall (r= -0-375,
P= 023).
At 3 days after cell-wall injection, six rats in the
group injected only with cell wall, and six rats in the'
COV plus cell wall group were killed and the right
anklejoints were collected for histological comparison
of the severity of inflammation and estimation of
cell-wall deposition in the tissue. By this subjective
assessment, the mean grade of inflammation in the
periarticular tissues of the ankle joint was 3 0 in the
group receiving only cell wall, compared with 2-2 in
the group treated with COV and cell wall. Inflam-
mation of the synovium was given a mean grade
of 3-2 in the group given only cell wall and 1-6
in the group treated with COV and cell wall. By
immunofluorescence and PAS stain the cellular locali-
zation of cell wall antigen appeared comparable in
both groups.
Relationship of serum complement levels and joint score
to quantity of cell wall localized in ankle joints
The amount of cell wall in the articular and periarticu-
lar tissue of wrist and ankle joints was quantified by
RIA in the two groups of six rats killed at 3 days after
injection of cell-wall fragments. The relationship
between joint score and quantity of cell wall in tissue is
shown in Fig. 4. The correlation coefficients were 0-87
(P <0002) for the group injected with PBS and cell
wall and 0-65 (P<001) for the group injected with
COV and cell wall. The slope of the linear regression
line of the PBS plus cell wall group was 1 66 and the
slope for the COV plus cell wall group was 071. This
means that in COV-treated rats, an increase in the
amount of cell wall in joints is not accompanied by an
increase in severity ofjoint inflammation comparable
with that in rats not treated with COV. There was no
effect of COV treatment on the quantity of cell wall
localized in the joint tissue (logio mean= 3-63 + 0-6 ng
in the COV-treated group and logio mean = 3-63 + 0-3
ng in the group given only cell wall).
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complement components by macrophages activated
by cell-wall ingestion (DeCeulaer, Papazogiou &
Whaley, 1980; Smialowicz & Schwab, 1977).
0
d/ The positive correlation between serum haemolytic
0 T activity and severity of joint inflammation in COV-
treated rats is consistent with the concept that comple-
ment is participating in the early phases of disease,
0-t A \ although it is also conceivable that increased produc-
tion of complement is merely a response to more
severe inflammation. The lack of correlation between
serum complement level and joint score in rats not
/ A/ * treated with COV argues against this latter interpre-
tation. A caveat to these studies is that there may be
some residual complement below our level of detec-
A/ /̂ tion, and this may be adequate to fill the inflammatory
role of complement in some rats. A second caveat is
that COV may function through a mechanism other
than suppressing complement levels. It has been
2 4 ' reported, for example, that the isolated factor has23 4 5 phospholipase A2 activity (Jungi & Pepys, 1981).
Log1o ng cell wall per joint Nevertheless, COV treatment to reduce serum com-
(day 3 ) plement levels has been used in several experimental
lation of severity of inflammation in left wrist
models to help define the role of complement in tissue
e w q o c winjury. Lesions with prominent neutrophil partici-le joints with quantity of cell wall in the articular ato(Ccrnetl.190orivvmntfcular tissue of these joints. Cell wall only: wrist pation (Cochrane et al., 1970) or Involvement of
kle joint (h), r= 087, P <0-002. COV before cell macrophages (Schorlemmer et al., 1977; Jungi &
joint (0), ankle joint (v), r=0 65, P<0-01. Pepys, 1981; Lennon, Seybold, Lindstrom, Cochrane
linear regression line. & Ulevitch, 1978) are inhibited by this procedure.
Not all materials that activate the ACP in vitro can
DISCUSSION induce a profound depression ofcomplement levels in
vivo. Coonrod & Jenkins (1979) have reported that i.v.
ties demonstrate that pretreatment of rats injection of rats with endotoxin or heat-killed pneu-
reduces the acute inflammation induced by mococci induces only a slight reduction of haemolytic
on of PG-APS isolated from group A complement by 2 hr after injection, but this returns to
cal cell-wall fragments. This suggests that normal levels by 18 hr. Injection ofpneumococcal cap-
nt components are involved in the early sular polysaccharide induced no significant change.
his model of experimental arthritis. How- The severity of arthritis induced in the rat with
ssion of early inflammation did not affect PG-APS fragments correlates with the amount of
,sive, chronic course of the arthritis. Reduc- PG-APS localized in thejoint tissue (Fig. 4, this paper,
um complement below detectable levels by and Eisenberg et al., unpublished observations). A
nt with COV significantly reduced joint critical question is the mechanism by which bacterial
on over the first 3 days, but not thereafter. cell-wall debris gains access to synovial tissue. Since
the COV treatment that we used can COV treatment did not affect the amount ofPG-APS
omplement activity for 5 days in rats per joint, the role of complement in the pathogenesis
et al., 1970), the injection of cell walls of experimental arthritis is apparently not through an
ed this effect and induced a return toward effect on transport of cell wall into joint tissue.
the normal range ofserum complement by 3 days. This
may account for absence of any effect of COV on the
later phase ofexperimental arthritis. We postulate that
the enhanced level of complement in cell wall-injected
rats resulted from the stimulation of secretion of
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